Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FLGE
Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes
FLGE
|
+$499M |
| 2 |
FBGX
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
|
+$479M |
| 3 |
Merck
MRK
|
+$328M |
| 4 |
BAY
BAYER AG SPONS ADR
BAY
|
+$287M |
| 5 |
Lloyds Banking Group
LYG
|
+$275M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FBG
UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN
FBG
|
+$958M |
| 2 |
IBM
IBM
|
+$565M |
| 3 |
McDonald's
MCD
|
+$502M |
| 4 |
CSE
CAPITALSOURCE INC
CSE
|
+$95.8M |
| 5 |
PL
PROTECTIVE LIFE CORP
PL
|
+$66.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.81% |
| 2 | Healthcare | 13.89% |
| 3 | Technology | 12.13% |
| 4 | Industrials | 7.64% |
| 5 | Consumer Discretionary | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHC
226
Diversified Healthcare Trust
DHC
$2.17B
| $11.8M | 0.02% |
491,046
-1,258,281
| -72% | -$29.4M |
|
227
Omnicell
OMCL
$1.69B
| $11.8M | 0.02% |
+410,000
| New | +$11.1M |
|
228
CVS Health
CVS
$134B
| $11.7M | 0.02% |
155,365
+67,257
| +76% | +$5.08M |
|
229
Globe Life
GL
$14.2B
| $11.6M | 0.02% |
212,616
-3,288
| -2% | -$176K |
|
|
CELG
230
DELISTED
Celgene Corp
CELG
| $11.3M | 0.02% |
131,064
+56,422
| +76% | +$4.29M |
|
231
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $11.2M | 0.02% |
133,009
+3,532
| +3% | +$299K |
|
232
Walmart Inc
WMT
$884B
| $11.2M | 0.02% |
449,061
+202,083
| +82% | +$5.19M |
|
233
M&T Bank
MTB
$35.8B
| $11.2M | 0.02% |
90,063
+11,515
| +15% | +$1.4M |
|
234
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
| $11.1M | 0.02% |
332,032
+20,118
| +6% | +$653K |
|
|
ASNA
235
DELISTED
Ascena Retail Group, Inc.
ASNA
| $11M | 0.02% |
32,040
-84,964
| -73% | -$29M |
|
|
TSS
236
DELISTED
Total System Services, Inc.
TSS
| $10.9M | 0.02% |
346,666
+13,606
| +4% | +$417K |
|
237
Owens Corning
OC
$11.2B
| $10.8M | 0.02% |
278,149
+14,694
| +6% | +$604K |
|
238
Vanguard FTSE Developed Markets ETF
VEA
$230B
| $10.7M | 0.02% |
251,139
+79,610
| +46% | +$3.35M |
|
239
Omnicom Group
OMC
$21.8B
| $10.7M | 0.02% |
150,122
-27,485
| -15% | -$1.91M |
|
240
Prologis
PLD
$136B
| $10.6M | 0.02% |
257,917
-3,335
| -1% | -$137K |
|
|
MINI
241
DELISTED
Mobile Mini Inc
MINI
| $10.6M | 0.02% |
221,207
+59,862
| +37% | +$2.66M |
|
242
Emergent Biosolutions
EBS
$375M
| $10.5M | 0.02% |
468,757
+70,087
| +18% | +$1.63M |
|
243
Progressive
PGR
$124B
| $10.2M | 0.02% |
402,885
+35,931
| +10% | +$890K |
|
244
Harley-Davidson
HOG
$2.59B
| $10.2M | 0.02% |
145,586
+12,820
| +10% | +$903K |
|
245
Amgen
AMGN
$209B
| $10.1M | 0.02% |
85,316
+35,429
| +71% | +$4.1M |
|
246
Valero Energy
VLO
$92.6B
| $10.1M | 0.02% |
200,647
-25,292
| -11% | -$1.39M |
|
247
Hain Celestial
HAIN
$44.4M
| $9.89M | 0.02% |
223,000
+40,150
| +22% | +$1.79M |
|
248
Warner Bros
WBD
$63.9B
| $9.6M | 0.02% |
252,944
-21,063
| -8% | -$829K |
|
249
Regions Financial
RF
$26.3B
| $9.6M | 0.02% |
+903,781
| New | +$9.42M |
|
250
Synopsys
SNPS
$71.3B
| $9.47M | 0.02% |
243,985
-33,300
| -12% | -$1.27M |
|
Similar funds
Ken Fisher's Q2 2014 Portfolio in Review
As of Q2 2014, Ken Fisher held 668 positions worth $47.6B, up 7.3% from $44.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Fisher deployed $2.03B of net new capital in Q2 2014, opening 82 new positions and adding to 273 existing holdings. Its largest new stake was Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes: 5,003,089 shares worth $506M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN, an estimated $958M trimmed.
- Ken Fisher's largest Q2 2014 buy was Credit Suisse FI Large Cap Growth Enhanced Exchange Traded Notes: 5,003,089 shares worth $506M.
- Ken Fisher added most to Merck in Q2 2014, an estimated $328M increase.
- Ken Fisher's biggest Q2 2014 reduction was UBS AG LONDON BRH FISHER ENHANCED BIG CAP GROWTH ETN, cutting an estimated $958M.
- Ken Fisher fully exited CAPITALSOURCE INC in Q2 2014, selling an estimated $95.8M.
- Ken Fisher's ten largest holdings make up 23% of its $47.6B portfolio in Q2 2014.
- Ken Fisher opened 82 new positions and closed 70 in Q2 2014.
- Ken Fisher's portfolio value rose 7.3% quarter-over-quarter to $47.6B.
Based on Fisher Asset Management's 13F filing for Q2 2014, filed 25 Jul 2014.